Electrodeposition of Manganese (III) Phthalocyanine/ Reduced Graphene Oxide for Asymmetric Supercapacitor Devices.

In this study, two novel tetra-substituted manganese (III) phthalocyanines bearing (9H-carbazol-2-yl)oxy groups on peripheral (1) or non-peripheral (2) positions were prepared and used for modification of reduced graphene oxide (rGO) by applying a simple one-step electrodeposition technique for the first time. The manganese (III) phthalocyanines (MnPcs) were electropolymerized and graphene oxide was electrochemically converted into reduced graphene oxide simultaneously. Subsequently, an rGO-MnPc hybrid structure was formed directly on the NiF electrode (substrate) via layer-by-layer assembly.

Sonophotochemical and photochemical efficiency of thiazole-containing metal phthalocyanines and their gold nanoconjugates.

This study presents the synthesis of some metal {M = Zn(II), Lu(III), Si(IV)} phthalocyanines bearing chlorine and 2-(4-methylthiazol-5-yl) ethoxy groups at peripheral or axial positions. The newly synthesized metal phthalocyanines were characterized by applying FT-IR, H NMR, mass, and UV-Vis spectroscopic approaches. Additionally, the surface of gold nanoparticles was modified with zinc(II) and silicon(IV) phthalocyanines.

Supercapacitive properties of carbazole-containing cobalt(II) phthalocyanines/reduced graphene oxide composites.

This study aims to compare the effect of substituents (position and number) and reduced graphene oxide on the supercapacitive properties of cobalt(II) phthalocyanines. For this purpose, three new tetra- and octa-substituted cobalt(II) phthalocyanines bearing 9-carbazol-2-yloxy groups on peripheral or non-peripheral positions (1-3) were synthesized. The characterization of the resultant cobalt(II) phthalocyanines was carried out by applying several spectroscopic approaches.

Design of N-heterocycle based-phthalonitrile/metal phthalocyanine-silver nanoconjugates for cancer therapies.

This study reports the anticancer properties of carbazole-containing phthalonitrile/phthalocyanine-modified silver nanoparticles for the first time. In this study, a new mono-substituted phthalonitrile namely 3-[9-carbazole-9-ethoxy]phthalonitrile and its metal phthalocyanines {M = Zn, Co, and Mn(Cl)} were synthesized by template cyclotetramerization of phthalonitrile derivatives. The newly synthesized compounds were characterized using UV-vis, FT-IR, H NMR, C NMR, and mass spectroscopy.

Effect of Axial Ligand Length on Biological and Anticancer Properties of Axially Disubstituted Silicon Phthalocyanines.

In this study, three new axially disubstituted silicon phthalocyanines (SiPc1-3) and their quaternized phthalocyanine derivatives (QSiPc1-3) were prepared and characterized. The biological properties (antioxidant, antimicrobial, antibiofilm, and microbial cell viability activities) of the water-soluble silicon phthalocyanines were examined, as well. A 1 % DMSO diluted with pure water was used as a solvent in biological activity studies.

Anticancer and biological properties of new axially disubstituted silicon phthalocyanines.

This study reports the synthesis of three novel axially disubstituted silicon phthalocyanines (1-3-Si) and their quaternized phthalocyanines (1-3-QSi). The resulting compounds were characterized by applying spectroscopic techniques including H NMR, FT-IR, UV-vis, and mass spectroscopy. The biological properties of compounds 1-3-QSi, including DNA cleavage activities, DNA binding modes, and topoisomerase enzyme inhibition activities, were investigated using agarose gel electrophoresis.

New phthalonitrile/metal phthalocyanine-gold nanoparticle conjugates for biological applications.

The emergence of nanoscience and its effect on the development of diverse scientific fields, particularly materials chemistry, are well known today. In this study, a new di-substituted phthalonitrile derivative, namely 4,5-bis((4-(dimethylamino)phenyl)ethynyl)phthalonitrile (1), and its octa-substituted metal phthalocyanines {M = Co (2), Zn (3)} were prepared. All the newly synthesized compounds were characterized using a number of spectroscopic approaches, including FT-IR, mass, NMR, and UV-vis spectroscopy.

Investigation of the photoconductive properties of thiophene substituted metallo-phthalocyanines.

The synthesis of 4-(thiophen-3-ylethynyl)phthalonitrile was achieved via the Sonogashira cross-coupling reaction. Herein, we report the synthesis of symmetrical metallo-phthalocyanines with cobalt, zinc, and manganese as the metal ions, and tetrakis(ethynylthiophene) groups substituted at the peripheral positions. The new compounds have been characterized by using mass, H NMR, C NMR, FT-IR and UV-vis spectroscopy.

Sensing alcohol vapours with novel unsymmetrically substituted metallophthalocyanines.

Unsymmetrically substituted phthalocyanines were synthesized by the well-known statistical condensation method using two differently substituted precursors, 4-tert-butylphthalonitrile and 4-(4-pyrrol-1-yl)phenoxyphthalonitrile. Spin-coated thin films of these compounds were subsequently exposed to varying concentrations of methanol, ethanol and butanol between 25 and 150 ppm in order to investigate the effects of the number of carbon atoms in the alcohol vapors. The results of this preliminary investigation indicated that sensor performance parameters such as sensitivity, response and recovery time strongly depend on the number of carbon atoms in the analyte molecules.

Microwave-assisted synthesis of novel non-peripherally substituted metallophthalocyanines and their sensing behaviour for a broad range of Lewis bases.

The synthesis of novel, symmetrical, tetrasubstituted metallophthalocyanines (cobalt, zinc, and manganese) bearing four 2-(4-methyl-1,3-thiazol-5-yl)ethoxy units is reported. The new compounds have been characterized using UV-Vis, IR, (1)H NMR, (13)C NMR, and mass spectroscopy data. Photophysical properties of zinc(ii) phthalocyanines were found, including electronic absorption and fluorescence quantum yields.

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.

The prognosis of relapsed acute leukemia or chronic leukemia in acute blast crisis is poor and new chemotherapeutic regimens could be useful for these patients. Six relapsed acute lymphoblastic leukemia (ALL), nine relapsed acute myeloblastic leukemia (AML), one chronic myelomonocytic leukemia (CMML) and one chronic myeloid leukemia (CML) in acute blast crisis between three to 18 years (median 10 years) received fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) chemotherapy (CT). Five of the AML relapses were after bone marrow transplantation (BMT) and four were recurrent relapses.